Shenzhen Kangtai Stock Hits Day Low Amid Price Pressure, Closing at CNY 13.83

Shenzhen Kangtai Biological Products Co., Ltd. experienced a notable decline today, with the stock dropping by 4.16% and reaching an intraday low of CNY 13.83. This performance marks a significant underperformance compared to the China Shanghai Composite, which fell by only 1.26% on the same day. Over the past week, Shenzhen Kangtai has seen a decrease of 7.36%, and its one-month performance reflects a decline of 10.54%. The stock's year-to-date performance stands at -6.3%, while it has faced a staggering drop of 59.65% over the last three years. In the longer term, the stock has plummeted by 85.53% over the past five and ten years, indicating persistent challenges in maintaining growth. Financial metrics reveal that the company has reported negative results for five consecutive quarters, with a net profit of CNY -127.46 million, reflecting a decline of 158.57%. The operating cash flow is at its lowest, and net sales have also decreased by 13.08%. With a market capitalization of CNY 12,826 million, Shenzhen Kangtai continues to face significant hurdles in its financial performance within the pharmaceuticals and biotechnology sector.